Abstract
Oral anticoagulants [OACs; Vitamin K antagonists (VKAs) and direct-acting anticoagulants (DOACs)] are effective for preventing stroke in patients with atrial fibrillation (AF). Switching between OACs occurs because of the unique safety, effectiveness, and convenience attributes of each OAC, and patient factors. Studies on factors associated with OAC switching have been limited to switches from VKA to DOAC and data on other OAC class switches are sparse. The objective of this study was to determine factors associated with OAC switching for VKA to DOAC, DOAC to VKA, and DOAC to DOAC switches.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
